Genetic Engineering & Biotechnology Newsflipped into Genetic Engineering & Biotechnology News2 hours agoTissue Biomanufacturing Progresses, but Still a Way to GoGenetic Engineering & Biotechnology News - Gail DuttonAssembling organ building blocks (OBBs) will become a viable method to create human tissue to fill the gaps in organ donation. But, despite more than …
Genetic Engineering & Biotechnology Newsflipped into Genetic Engineering & Biotechnology News2 hours agoTraining Bioprocessors with Virtual RealityGenetic Engineering & Biotechnology News - Mike May, PhDTraining personnel creates fundamental challenges in bioprocessing. These challenges include limitations in access to the equipment and trainers, as …
Genetic Engineering & Biotechnology Newsflipped into Genetic Engineering & Biotechnology News2 hours agoGroundwork Established for Continuous MonitoringGenetic Engineering & Biotechnology News - Vivienne Raper, PhDA team of scientists is laying the groundwork for ensuring the long-term stability of continuous processes. The researchers, from the lab of Anurag …
Genetic Engineering & Biotechnology Newsflipped into Genetic Engineering & Biotechnology News2 hours agoHolographic Microscopy Helping Biopharma Keep an Eye on Cell CultureGenetic Engineering & Biotechnology News - Gareth John MacdonaldDigital tools are allowing drug makers to monitor cell cultures in more detail than ever before, according to Ultragenyx, which says a new …
Genetic Engineering & Biotechnology Newsflipped into Genetic Engineering & Biotechnology News5 hours agoCorneal T Cells Produce Limited Immune Response to Protect Eyes from Viral InfectionsGenetic Engineering & Biotechnology News - John SterlingResearchers from the Peter Doherty Institute for Infection and Immunity report that the cornea produces a delicate and limited immune response to …
Genetic Engineering & Biotechnology Newsflipped into Genetic Engineering & Biotechnology News5 hours agoWhich SARS-CoV-2 Variant Will Cause the Next Wave? An AI Tool PredictsGenetic Engineering & Biotechnology News - Julianna LeMieux, PhDFirst, there was Delta. Then Omicron. Now, it’s the Omicron subvariant BA.2.12.1. And, public health officials are keeping a close watch on the BA.4 …
